{
    "code": "06014880",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06014880",
    "time": "2019-12-06 03:49:33",
    "許可證字號": "衛署醫器輸字第014880號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/11\/21",
    "發證日期": "94\/11\/21",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00601488003",
    "中文品名": "希摩西爾第七凝固因子缺乏血漿",
    "英文品名": "HemosIL Factor VII deficient plasma",
    "效能": "以免疫去除法去除血漿中的第七因子，提供在IL與ELECTRA血液凝固系統上配合凝血&#37238;原試劑測定檸檬酸化血漿中的第七因子濃度。",
    "醫器規格": "#0008466250: 5x1 mL, #0020011700: 10x1 mL, 以下空白。\r\n註銷規格：0008466250。",
    "劑型": "",
    "包裝": "",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "640110B420  台灣沃芬有限公司",
        "申請商地址": "臺北市內湖區堤頂大道二段501號4樓",
        "主製造廠": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060148800001___20110627.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06014880&Seq=001&Type=9"
        },
        {
            "title": "060148800002___20110627.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06014880&Seq=002&Type=8"
        },
        {
            "title": "060148800001___20110627.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06014880&Seq=001&Type=8"
        }
    ]
}